Arnold & Porter
Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
Your LinkedIn Connections
with the authors
Generating articles
loading
Generating authors
loading
Generating guides
loading
Arnold & Porter
Please join Arnold & Porter for our annual discussion of regulatory and enforcement trends for anti-money laundering and sanctions in the year ahead.
Arnold & Porter
Please join us for a webinar series on the major antitrust developments from 2021, as presented by members of our full-service antitrust/competition team.
Arnold & Porter
Six Arnold & Porter attorneys were named to the 2022 Lawdragon 500 Leading US Bankruptcy and Restructuring Lawyers.
Arnold & Porter
Arnold & Porter is pleased to announce that its formal plan to become Black Equity at Work Certified has been approved by Management Leadership for Tomorrow (MLT).
Arnold & Porter
The inaugural edition of the Chambers Greater China Region guide highlighted Arnold & Porter as a "Leading Firm" in Life Sciences and recognized two attorneys as "Leading Individuals" in its 2022 edition.
Arnold & Porter
This webinar will focus on the new era of shareholder engagement and its impact on life sciences companies.
Arnold & Porter
NEW YORK, NY, January 18, 2022 — Arnold & Porter announced today that Mélida Hodgson has joined the firm’s International Arbitration practice as a partner, resident in New York.
Arnold & Porter
Kick Off The New Year With Qui Notes: False Claims Act FY2021 Year In Review And An Early Look At FY2022
Arnold & Porter
Congressional investigations present significant risks for companies and individuals. Regardless of whether the investigation involves televised hearings or routine inquiries,...
Arnold & Porter
Congressional investigations present significant risks for companies and individuals. Regardless of whether the investigation involves televised hearings or routine inquiries...